SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-032783
Filing Date
2021-06-14
Accepted
2021-06-14 16:20:31
Documents
12
Period of Report
2021-06-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K adpt-8k_20210611.htm   iXBRL 8-K 61160
  Complete submission text file 0001564590-21-032783.txt   191977

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA adpt-20210611.xsd EX-101.SCH 5804
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE adpt-20210611_lab.xml EX-101.LAB 19473
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adpt-20210611_pre.xml EX-101.PRE 11651
5 EXTRACTED XBRL INSTANCE DOCUMENT adpt-8k_20210611_htm.xml XML 3575
Mailing Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38957 | Film No.: 211014829
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences